US FDA approves Asahi Kasei drug for persistent herpes sores
FDA approved Asahi Kasei’s drug for persistent herpes simplex virus sores in certain patients with weakened immune systems who did not respond to available antiviral treatments.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.